In the Pulmonary Vascular Disease Phenomics [PVDOMICS] study, the NHLBI plans to assemble a comprehensive cohort of PH patients across the World Health Organization (WHO) groups 1 through 5, in order to apply phenomic methods and system biology approaches to redefine classifications based on pathobiologic mechanisms.
|Effective start/end date||8/1/15 → 7/31/19|
- Cleveland Clinic Lerner College of Medicine of CWRU (1060-SUB//5U01HL125177-05)
- National Heart, Lung, and Blood Institute (1060-SUB//5U01HL125177-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.